Return to avella.com

In the News

1 2 36
Showing 110 of 57 Items
2013’s Fastest-Growing, Private Specialty Pharmacies
September 03, 2014

2013’s Fastest-Growing, Private Specialty Pharmacies

Time for our annual review of the Inc. 5000 list, Inc. magazine’s ranking of the fastest-growing private U.S. companies. Once again, the Inc. 5000 list highlights the boom in specialty drug dispensing. The 2014 list, which is based upon revenue growth through 2013, includes 13 specialty pharmacies. The pharmacies and key stats are listed below. Total revenues for the group were $3.1 billion. Diplomat, with $1.5 billion in revenues, accounted for half of the total.
Avella Has Introduced Online and Mobile Prescription Management Tools for Patients
August 28, 2014

Avella Has Introduced Online and Mobile Prescription Management Tools for Patients

This summer, Avella Specialty Pharmacy launched a new patient portal and a stand-alone mobile application that allows customers to manage their prescriptions from their mobile phone. By logging into either of these secure tools, patients can quickly and easily request prescription refills, view their prescription history and transfer prescriptions between pharmacies. Not only do these new tools offer greater convenience, they also help Avella’s customers maintain their health and safety by providing access to refill reminders and important information about medications.
Get Appy! New Tech a Bridge To Patient Care
August 27, 2014

Get Appy! New Tech a Bridge To Patient Care

As of January 2014, 90% of American adults own a cell phone, and 58% of adults have a smartphone, according to a study by Pew Research (http://bit.ly/​1fvWYrL). In fact, as of 2011, there are more mobile phones, tablets and other wireless devices in the United States than there are people—a trend that could soon have a profound effect on the services that specialty pharmacy provides to patients.
How Do Outsourcing Facilities Ensure Safety of Sterile Compound Drugs?
August 13, 2014

How Do Outsourcing Facilities Ensure Safety of Sterile Compound Drugs?

Phoenix—Recent legislation helps providers identify pharmacies that maintain current good manufacturing practices (cGMPs), but what does that mean? And how can a facility ensure that it is dealing with a good compounding pharmacy?
The 5 Biggest Challenges for Stakeholders in the Oncology Value Chain
July 08, 2014

The 5 Biggest Challenges for Stakeholders in the Oncology Value Chain

Interview with Rebecca M. Shanahan, CEO of Avella Specialty Pharmacy, a speaker at IIR's upcoming Annual Summit for Oncology Management, July 21-23, in Philadelphia.
Avella Specialty Pharmacy attorney fulfills lifelong desire through medicines
June 29, 2014

Avella Specialty Pharmacy attorney fulfills lifelong desire through medicines

Rebecca Shanahan spends a lot of her time dealing with orphans. Not people: drugs. "Orphan drugs are those needed by a small population of patients, usually 6,000 or fewer," says Shanahan, CEO of Avella Specialty Pharmacy. "The challenge for drug manufacturers is that they have to put all of the effort into research, development and testing. Often times, the cost of getting the drug from its inception to market requires a disproportionate expense as compared to what the return on the investment would be."
Specialty Pharmacy Treatment Strategies for Lung Cancer
May 23, 2014

Specialty Pharmacy Treatment Strategies for Lung Cancer

Donna M. Smith, Pharm.D., director of clinical affairs at Avella Specialty Pharmacy discusses developments in the treatment of lung cancer that specialty pharmacies need to be aware of. This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.
Armada Summit CE Session Lung Cancer Patient Management and Specialty Pharmacies
May 20, 2014

Armada Summit CE Session Lung Cancer Patient Management and Specialty Pharmacies

Emerging therapies and the role of specialty pharmacies in the treatment of non-small cell lung cancer were discussed during a continuing education session at the annual Armada summit.
Managing Rising Costs and Improving Outcomes for Specialty Pharmacy Patients
May 12, 2014

Managing Rising Costs and Improving Outcomes for Specialty Pharmacy Patients

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients. This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.
Otezla Distributors Focus on Patient Care
May 01, 2014

Otezla Distributors Focus on Patient Care

Patient care, communication and coordination take center stage as Diplomat Specialty Pharmacy, Avella Specialty Pharmacy, Amber Pharmacy and 32 other select companies begin distributing apremilast, the first FDA-approved oral therapy for psoriatic arthritis.
1 2 36
Showing 110 of 57 Items

From the Avella Blog

December 12, 2014

Q&A: Understanding the Complexities of Treating Oncofertility Patients

A highly-experienced clinician details the challenging, but incredibly rewarding process of improving fertility in patients undergoing cancer treatment. The following interview with Andrea Speck-Zulak, RNC, Director of Nursing at Oregon Reproductive Medicine, provides unique insight into how one thriving oncofertility practice supplements the healing process by providing patients with hope for the future.  This article was originally published in the latest issue of Dispensing Excellence, a ...